Neuroimaging Course
Educational Objectives
- Develop enhanced skills in identifying MS lesions using a clinical-anatomical approach.
- Understand and apply the updated McDonald criteria and latest NMOSD imaging criteria.
- Recognize and integrate new MRI biomarkers into clinical practice for improved diagnosis and management.
- Foster multidisciplinary collaboration by correlating imaging findings with clinical context.
Neuro-ophthalmological Course
Educational Objectives
- Interpret OCT, VEP, visual field tests, and fluorescein angiography in neuro-ophthalmic MS presentations.
- Integrate neuro-ophthalmological tools with updated diagnostic criteria for MS and related disorders.
- Promote multidisciplinary clinical collaboration for patients with visual symptoms and MS.
- Identify OCT advancements and areas of potential utilization in MS and other neuro-inflammatory conditions.
Pre-MENACTRIMS Symposium — Neuroimaging Course Case-based • 2 hours
Focused neuroimaging training for MS presentations across visual, hemispheric, brainstem, and spinal pathways.
This Pre-MENACTRIMS Neuroimaging Course is a 2-hour program dedicated to improving diagnostic confidence in multiple sclerosis (MS) through imaging-based case discussions. Led by international experts, the course systematically reviews presentations of MS in different CNS regions with practical case illustrations.
- Time
- 09:00–11:00
- Date
- Thursday, December 4, 2025
- Venue
-
Al Baraha 1, Intercontinental Hotel – Festival City
Dubai, United Arab Emirates
Program
09:00–11:00 | Neuroimaging Course Chairs: XXX | |
09:00–09:30 | Optic Neuritis (Visual) Presentation for MS | M. Aboulwafa Ali (UK) |
09:30–10:00 | Hemispheric (Sensorimotor) Presentation for MS | M. Aboulwafa Ali (UK) |
10:00–10:30 | Brainstem Presentation for MS | M. Aboulwafa Ali (UK) |
10:30–11:00 | Spinal Cord Presentation for MS | M. Aboulwafa Ali (UK) |
Faculty

Queen Mary University of London
– NHS England

Queen Mary University of London
– NHS England

Queen Mary University of London
– NHS England

Queen Mary University of London
– NHS England
Target Audience
- Specialists
- Neurologists
- Practitioners
- Researchers in the field of MS
Registration
Registration is complimentary. The Merck Medical Grand Rounds content is developed for use outside of the US and is intended for non-US HCPs.
GL-MAV-01489 | December 2025
This medical program is funded and organized by Merck Healthcare
KGaA, an affiliate of Merck. It is intended for healthcare professionals
only, (excluding US healthcare professionals). The materials shown
are intended for discussion purposes and must not be considered
medical advice from healthcare professional. Scientific opinions
presented therein do not necessarily represent the position of Merck.
It is not intended to promote the use of any products. Prescribing
information may vary depending on local approval in each country.
Therefore, before prescribing any product, always refer to locally
approved prescribing information and/or the Summary of Product
Characteristics (SmPC). The presentations may contain information
on products and/or product combinations outside of the approved
label in the EU and/or in your country.
For any further information regarding the approval status of a specific
product in your country, please refer the applicable product labelling
information in your country of practice.
© 2025 Merck KGaA, Darmstadt Germany and/or its affiliates.
All rights reserved.

Neurology Institute
American University of Beirut,
Harley Street Medical Centre
St. Michael’s Hospital, University of Toronto
Neurology Institute
American University of Beirut,
Harley Street Medical Centre
of Neurology
University Hospital San Carlos
Queen Mary University of London
– NHS England